Navigation Links
The Growing Role of Medical Science Liaisons in the Pharmaceutical Industry

CHAPEL HILL, N.C., Oct. 18, 2013 /PRNewswire/ -- Although Medical Science Liaisons (MSLs) have been around for decades, their roles, activities, and importance continue to grow. With competition for the time and attention of physicians and Key Opinion Leaders (KOLs) intensifying, companies rely on MSLs' skills to build and strengthen key relationships.

MSL involvement in identifying and forging relationships with KOLs has increased by more than 20 percent since 2009, according to research by leading research & consulting firm, Best Practices, LLC. These relationships provide critical windows of insight into the market and competition and yet this key MSL activity has become challenging in the face of a changing regulatory and access environment.

The report, "Roles, Resourcing and Management of Medical Science Liaisons," provides medical leaders with key metrics to help them navigate the new KOL landscape. The research also highlights emerging trends in Medical Affairs - the group where MSL operations are typically housed.

The key topics covered in this report include:

  • Benchmark Pre and Post-Launch Service Activities
  • Identify Drivers of Group Size & Focus
  • Gain insight into Structuring & Aligning Medical With Sales Organizations
  • Identify Optimal Call Frequencies and Service Levels with Thought Leaders
  • Identify Relationship Management Standards of Excellence
  • Value Associated with MSL
  • Budget Allocation to MSLs

This benchmarking research drew participation from 27 leaders with 24 companies, including 10 of the Top 20 Pharma organizations. Insights and observations were distilled from interviews and benchmark performance data.

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link:

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC Web site at 


Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Industry Veteran Brings Sales Expertise to AlloSources Growing Distribution Network
2. Konica Minolta Sensing America Launches Spanish Website in Support of Growing Demand In Latin American Countries
3. Frost & Sullivan: Next-Generation Sequencing Services is one of the Fastest Growing Markets in the Life Sciences Industry
4. TSI Healthcare adds Arthritis and Rheumatology Associates of Palm Beach to growing list of Rheumatology Clients
5. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
6. CPhI China 2012 Breaks Attendance Records in Growing Pharma Market
7. E-Prescribing Trend is Growing; Pennsylvania Ranks 11th in Nation
8. Vesta Inc. Opens Frankfurt Office to Increase Service to Their Growing Medical Device Contracting Business Overseas
9. Comprehensive Care Corporation Names Jairo Estrada Senior Management Advisor To Assist in Growing the Companys New Pharmacy Initiatives
10. Central Logic Named To 2012 Inc. 500 Fastest Growing Private Companies
11. Medical Alarm Concepts Begins Shipments To Europe - Company Ordering Additional Inventory To Keep Up With Growing Demand
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... -- Allergan plc (NYSE: AGN ) today announced that ... York State Attorney General,s Office to end the ... statutes with the Attorney General over the decision of Forest ... selling the now generic version of memantine immediate release tablets.  ... released its counterclaims against New York , ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 2015 , ... The men and women on this list ... the country. They have overseen financial turnarounds, shown commitment to their community through ... as a whole through their advocacy and professional efforts. , Becker's Hospital Review ...
(Date:11/27/2015)... San Francisco, California (PRWEB) , ... November 27, 2015 , ... ... 1969 Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of ... 1969 at the Canterbury House at the University of Michigan in Ann Arbor. The ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point Recovery, ... together on Thanksgiving Day to share the things that they are most grateful ... Point YouTube channel, patients displayed what they wrote on index cards, describing the ...
(Date:11/26/2015)... ON and Cambridge, ON (PRWEB) , ... November ... ... today the availability of a real-time eReferral system for diagnostic imaging in the ... ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic medical ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
Breaking Medicine News(10 mins):